«Cannabis and Cannabinoids». National Cancer Institute. 24 Οκτωβρίου 2011. Ανακτήθηκε στις 12 Ιανουαρίου 2014.
doi.org
dx.doi.org
Schütz, Sonja G.; Dunn, Abbey; Braley, Tiffany J.; Pitt, Bertram; Shelgikar, Anita V. (2021). «New frontiers in pharmacologic obstructive sleep apnea treatment: A narrative review». Sleep Medicine Reviews (Elsevier BV) 57: 101473. doi:10.1016/j.smrv.2021.101473. ISSN1087-0792. PMID33853035. «"Initial rodent studies showed that injections of dronabinol, a synthetic form of delta-9-tetrahydrocannabinol, in the nodose ganglia suppressed serotonin induced reflex apneas and increased upper airway dilating muscle activity during sleep. Limited studies in humans with moderate-to-severe OSA have demonstrated significant reduction in AHI with dronabinol use."».
«Marinol (Dronabinol)»(PDF). US Food and Drug Administration. Σεπτεμβρίου 2004. Ανακτήθηκε στις 14 Ιανουαρίου 2018.
nih.gov
ncbi.nlm.nih.gov
Schütz, Sonja G.; Dunn, Abbey; Braley, Tiffany J.; Pitt, Bertram; Shelgikar, Anita V. (2021). «New frontiers in pharmacologic obstructive sleep apnea treatment: A narrative review». Sleep Medicine Reviews (Elsevier BV) 57: 101473. doi:10.1016/j.smrv.2021.101473. ISSN1087-0792. PMID33853035. «"Initial rodent studies showed that injections of dronabinol, a synthetic form of delta-9-tetrahydrocannabinol, in the nodose ganglia suppressed serotonin induced reflex apneas and increased upper airway dilating muscle activity during sleep. Limited studies in humans with moderate-to-severe OSA have demonstrated significant reduction in AHI with dronabinol use."».
Schütz, Sonja G.; Dunn, Abbey; Braley, Tiffany J.; Pitt, Bertram; Shelgikar, Anita V. (2021). «New frontiers in pharmacologic obstructive sleep apnea treatment: A narrative review». Sleep Medicine Reviews (Elsevier BV) 57: 101473. doi:10.1016/j.smrv.2021.101473. ISSN1087-0792. PMID33853035. «"Initial rodent studies showed that injections of dronabinol, a synthetic form of delta-9-tetrahydrocannabinol, in the nodose ganglia suppressed serotonin induced reflex apneas and increased upper airway dilating muscle activity during sleep. Limited studies in humans with moderate-to-severe OSA have demonstrated significant reduction in AHI with dronabinol use."».